Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Trends, Share, Industry Size, Growth, Demand, Opportunities and Forecast By 2029 -…

Autologous Stem Cell and Non-Stem Cell Based Therapies Marketbusiness report provides detailed information on important aspects such as drivers and constraints that define the future growth of the market. This business report includes both qualitative and quantitative aspects of the industry in each region and country mentioned in the market research study

Read more
Stem Cells Market Size will Observe Lucrative Surge by the End 2028 – Digital Journal

Stem Cells Market Outlook 2028 Analysts Viewpoint on Stem Cells Market Scenario Stem cells are used in treating various illnesses in the body. Technological advancements in healthcare and pharmaceutical industries are creating potential revenue opportunities for market players operating in the stem cells market. Increasing investments in R&D activities to explore innovative ways to use stem cells for different healthcare applications are driving the global stem cells market.

Read more
Can a Magic Protein Slow the Aging Process? – The New York Times

This article is part of Upstart, a series about young companies harnessing new science and technology. Several years ago, scientists studying aging at the Harvard Stem Cell Institute used a somewhat Frankensteinian technique known as parabiosis surgically joining a young mouse and an old mouse so that they share blood to see what would happen to the heart and skeletal muscle tissue.

Read more
Cell Culture Market 2021 By Emerging Trends, Industry Share, Regional Overview and SWOT Analysis till 2031 – Digital Journal

Cell Culture Market: Introduction According to the report, the globalcell culture marketwas valued at US$10.5Bn in 2020 and is projected to expand at a CAGR of9%from 2021 to 2031. The global cell culture market is driven by development of new products, technological advancements, and increase in use of single-use bioprocessing systems during the forecast period. The cell culture market in Asia Pacific is anticipated to expand at the fastest CAGR during the forecast period due to high unmet clinical needs, improvements in the healthcare infrastructure, and increase in focus on research & development activities

Read more
Survey Identifies Obstacles to Adoption of CAR T-Cell Therapy for DLBCL – Targeted Oncology

Bruce Feinberg, DO, vice president and chief medical officer of Cardinal Health Specialty Solutions, discusses a survey researching chimeric antigen receptor (CAR) T-cell therapys growing usage by community oncologists for diffuse large B-cell lymphoma (DLBCL). The results of this survey of community oncologists have shown there are still obstacles to the adoption of CAR T-cell therapy, Feinberg says. The survey explored factors such as rate at which oncologists now use CAR T-cell therapy, their perceptions of the therapy, and what barriers they face in getting patients this treatment.

Read more